Rafferty Asset Management, LLC Dynavax Technologies Corp Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 262,358 shares of DVAX stock, worth $3.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

262,358

Previous 311,686 15.83%

Holding current value

$3.37 Million

Previous $3.5 Million 16.51%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.05 - $11.61 $495,746 - $572,698	-49,328 Reduced 15.83%	262,358 $2.92 Million
Q2 2024 Aug 13, 2024	SELL	$10.73 - $12.58 $4.14 Million - $4.86 Million	-386,221 Reduced 55.34%	311,686 $3.5 Million
Q1 2024 May 13, 2024	BUY	$11.7 - $14.98 $1.84 Million - $2.36 Million	157,588 Added 29.17%	697,907 $8.66 Million
Q4 2023 Feb 13, 2024	BUY	$13.09 - $14.98 $833,636 - $954,001	63,685 Added 13.36%	540,319 $7.55 Million
Q3 2023 Nov 13, 2023	BUY	$12.64 - $14.99 $626,413 - $742,874	49,558 Added 11.6%	476,634 $7.04 Million
Q2 2023 Aug 11, 2023	SELL	$9.85 - $13.17 $1.12 Million - $1.5 Million	-113,963 Reduced 21.06%	427,076 $5.52 Million
Q1 2023 May 11, 2023	SELL	$9.44 - $11.88 $999,205 - $1.26 Million	-105,848 Reduced 16.36%	541,039 $5.31 Million
Q4 2022 Feb 13, 2023	BUY	$10.27 - $13.29 $534,758 - $692,010	52,070 Added 8.75%	646,887 $6.88 Million
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $3.28 Million - $5.76 Million	330,400 Added 124.95%	594,817 $6.21 Million
Q2 2022 Aug 12, 2022	SELL	$7.45 - $12.83 $2.12 Million - $3.64 Million	-284,004 Reduced 51.79%	264,417 $3.33 Million
Q1 2022 May 13, 2022	BUY	$9.75 - $14.44 $1.49 Million - $2.21 Million	152,838 Added 38.64%	548,421 $5.95 Million
Q4 2021 Feb 10, 2022	BUY	$13.17 - $20.94 $2.87 Million - $4.57 Million	218,022 Added 122.79%	395,583 $5.57 Million
Q3 2021 Nov 10, 2021	SELL	$9.16 - $19.83 $976,364 - $2.11 Million	-106,590 Reduced 37.51%	177,561 $3.41 Million
Q2 2021 Aug 10, 2021	SELL	$7.25 - $10.99 $461,448 - $699,491	-63,648 Reduced 18.3%	284,151 $2.8 Million
Q1 2021 May 10, 2021	BUY	$4.57 - $11.18 $985,314 - $2.41 Million	215,605 Added 163.1%	347,799 $3.42 Million
Q4 2020 Feb 10, 2021	SELL	$3.73 - $5.6 $984,138 - $1.48 Million	-263,844 Reduced 66.62%	132,194 $588,000
Q3 2020 Nov 13, 2020	BUY	$4.32 - $11.7 $1.46 Million - $3.95 Million	337,240 Added 573.56%	396,038 $1.71 Million
Q2 2020 Aug 07, 2020	BUY	$2.94 - $9.1 $141,872 - $439,129	48,256 Added 457.75%	58,798 $522,000
Q1 2020 May 15, 2020	SELL	$2.27 - $6.2 $179,261 - $489,614	-78,970 Reduced 88.22%	10,542 $37,000
Q4 2019 Feb 10, 2020	BUY	$3.46 - $6.93 $309,711 - $620,318	89,512 New	89,512 $512,000
Q2 2019 Aug 09, 2019	SELL	$3.65 - $7.89 $656,091 - $1.42 Million	-179,751 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.08 - $12.09 $1.27 Million - $2.17 Million	179,751 New	179,751 $1.31 Million

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.62B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Dynavax Technologies Corp Transaction History